Clinical trials
Evaluation clinical trials
Below are recruiting evaluation clinical trials, each written for real people, not researchers. We’re tracking 5,382 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06510751Recruiting
CGRP and substance P in meningitis ICU patients
This study measures two natural chemicals (CGRP and substance P) in adult ICU patients with suspected meningitis. It aims to see if their levels help diagnose or understand meningitis better.
AntalyaAges 18 years+ - NCT06510868Recruiting
MDS risk study for NET patients before or after PRRT
This study looks at the risk of developing Myelodysplastic Syndrome (MDS), a blood disorder, in people with Neuroendocrine Tumors (NET) who are treated with Peptide Radionuclide Therapy (PRRT). It involves a simple blood test to check for genetic changes linked to MDS. Participating can help understand and potentially prevent this side effect.
Toronto, OntarioAges Any age - NCT06512064Recruiting
Breath sound test for lung health
This study tests a new device that listens to your breathing to check lung health. It is for healthy people and those with asthma, COPD, CF, or other airway diseases.
Indianapolis, IndianaAges 8–70 - NCT06512389RecruitingPhase 2
Testing CBD for alcohol cravings
This study tests whether a medication called cannabidiol (CBD) can help reduce cravings for alcohol. Over several weeks, you will take the study pill and attend lab sessions where you can choose to drink alcohol in a safe setting.
Toronto, OntarioAges 19 years+ - NCT06513065RecruitingPhase 3
Lower dose vs standard dose HIPEC for pseudomyxoma peritonei
This trial compares a lower dose of heated chemotherapy (HIPEC) given during surgery to a standard dose for patients with pseudomyxoma peritonei (a condition where jelly-like mucus builds up in the abdomen). The goal is to see if the lower dose works just as well with fewer side effects.
Basingstoke, HampshireAges 16 years+ - NCT06513039RecruitingPhase 4
Erythropoietin for preserving jawbone after tooth extraction
This trial tests whether a medicine called erythropoietin can help preserve the bone in your jaw after a tooth is pulled. It may help keep the area strong for future dental work.
CairoAges 18–40 - NCT06513910Recruiting
Studying how social music affects the brain
This trial looks at how listening to music with others changes brain activity. It may help us understand the social benefits of music.
New Haven, ConnecticutAges 16 years+ - NCT06514339RecruitingEarly Phase 1
Shenhuang granules for sepsis treatment
This trial tests if Shenhuang granules, a traditional Chinese medicine, can help treat sepsis (a life-threatening response to infection). It aims to see if it improves outcomes for patients with sepsis.
Hangzhou, ZhejiangAges 18 years+ - NCT06515015Recruiting
Trial of a plug for air leaks that won't heal after chest tube drainage
This trial tests a new silicone plug placed through a bronchoscope to stop air leaks in patients whose pneumothorax hasn't healed after a week of chest tube drainage. It aims to see if the plug is safe and works as a treatment for this condition.
Quanzhou, FujianAges 18 years+ - NCT06515821Recruiting
Improving colorectal cancer screening and diagnosis
This study collects data to improve how colorectal cancer is found and diagnosed. It compares new testing methods (like breath and stool tests) with standard colonoscopy in people with and without cancer or risk factors.
SofiaAges 18 years+ - NCT06516549Recruiting
Jumping rope for teens in South Africa
This study looks at whether jumping rope and an easy-to-read pamphlet can help teenagers stay active. If you join, you'll learn about exercise and try a fun activity (skipping rope) to see if it improves your health.
Durban, KwaZulu-NatalAges 10–14 - NCT06517251Recruiting
Arm-hand boost therapy for stroke recovery
This trial tests a special arm and hand therapy program for people who are still in the hospital after a stroke. If you have trouble using your arm or hand, this treatment may help you recover better.
Edegem, AntwerpenAges 18 years+ - NCT06519032Recruiting
AI Tool for Faster Bacterial ID in Lung Tests
This trial is testing a new AI tool that quickly identifies bacteria from your AFB test sample. If your doctor ordered this test, you can help see if the AI works well.
Suita, OsakaAges Any age - NCT06519552RecruitingPhase 1
Gene therapy study for adults with MPS type I
This study tests a new gene therapy called JWK008 for adults with MPS type I. The goal is to see if it is safe and can help improve symptoms. You may be able to join if you are 18 or older and have not had serious side effects from enzyme replacement therapy.
Chengdu, SichuanAges 18 years+ - NCT06520150Recruiting
Comparing two numbing methods for S-ICD heart device placement
This study compares two ways of numbing the chest area (regional anesthesia) for people getting an S-ICD heart device. The goal is to find which method works better and is safer for patients who are at higher risk for general anesthesia.
Wroclaw, Lower Silesian VoivodeshipAges 18–90 - NCT06521671Recruiting
Fracture healing after hip surgery in younger adults
This trial tests whether a new surgical method helps hip fractures heal better in adults aged 18 to 64. It uses special X-rays to track how the bone moves over time.
AarhusAges 18–65 - NCT06522828RecruitingPhase 2
Study of SSGJ-707 for advanced gynecologic cancers
This trial tests a new drug called SSGJ-707 for people with advanced endometrial cancer or ovarian cancer that no longer responds to platinum-based chemotherapy. The goal is to see if it can help shrink or slow down the cancer.
ChongqingAges 18–75 - NCT06525220RecruitingPhase 3
New drug combo vs. standard for head and neck cancer
This trial tests a new combination of two immunotherapy drugs (petosemtamab plus pembrolizumab) compared to pembrolizumab alone for people with head and neck cancer that has spread or come back and cannot be cured locally. It may be an option if your cancer has a certain protein (PD-L1) and you haven't had prior cancer treatment for this stage.
Mobile, AlabamaAges 18 years+ - NCT06525168RecruitingPhase 1
Safety study of DA414 in healthy volunteers
This trial tests a new medicine called DA414 in healthy people to see if it is safe and how the body processes it. It may help researchers understand the right dose for future studies.
Wuhan, Hubei.ChinaAges 18–45 - NCT06526247Recruiting
Testing programs for intimate partner violence in Washington state
This study tests support programs for men who have been court-referred for intimate partner violence in Washington state. It also includes their partners to see how well the programs work.
Boston, MassachusettsAges 18 years+ - NCT06526195Recruiting
A study of CardioMEMS and HeartMate 3 for advanced heart failure
This trial tests if a combination of a tiny lung-artery pressure sensor (CardioMEMS) and a mechanical heart pump (HeartMate 3) is safe and effective for people with advanced heart failure. If you qualify, you'll either get the heart pump plus standard medical therapy, or continue with standard therapy alone and have your pressure monitored remotely.
Phoenix, ArizonaAges 18 years+ - NCT06528184Recruiting
Comparing HPV testing methods for cervical cancer screening
This study compares different ways of testing for HPV (the virus that causes cervical cancer) during routine screening at primary care clinics. It aims to see which testing method works best to detect the virus and prevent cancer.
Singapore, SingaporeAges 30–69 - NCT06528444RecruitingPhase 3
Dexamethasone vs placebo for severe flu patients
This trial tests whether dexamethasone (a steroid) can help people hospitalized with severe flu recover faster. It is for adults who are already taking Tamiflu and do not have other serious infections like COVID-19.
AlicanteAges 18–100 - NCT06528431RecruitingPhase 4
Personalized tapering of adalimumab for rheumatoid arthritis
This study tests if checking the amount of adalimumab (a biologic drug) in your blood can help doctors safely lower your dose. If you have had rheumatoid arthritis under control for at least 6 months, this trial may help you take less medication while keeping symptoms away.
Caluire-et-CuireAges 18 years+
Hear when a new Evaluation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for evaluation?
- Yes. Clin2 currently lists 5,382 recruiting evaluation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a evaluation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a evaluation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.